 |
 |
|
North East and North Cumbria
ICS Formulary |
| Formulary Chapter 9: Nutrition and blood - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
09.01 |
Anaemias and some other blood disorders
(1,0)
|
|
09.01.01 |
Iron-deficiency anaemias (0,0)
|
|
09.01.01.01 |
Oral iron
(5,0)
|
|
|
Iron and folic acid (0,0)
|
|
|
Compound iron preparations (0,0)
|
|
09.01.01.02 |
Parenteral iron
(4,1)
|
|
09.01.02 |
Drugs used in megaloblastic anaemias
(2,0)
|
|
09.01.03 |
Drugs used in hypoplastic, haemolytic, and renal anaemias
(4,0)
|
|
|
Erythropoietin
(7,0)
|
|
|
Iron overload
(3,0)
|
|
09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura
(6,0)
|
|
09.01.05 |
G6PD deficiency (0,0)
|
|
09.01.06 |
Drugs used in neutropenia
(4,0)
|
|
09.01.07 |
Drugs used to mobilise stem cells
(1,0)
|
|
09.02 |
Fluids and electrolytes (0,0)
|
|
09.02.01 |
Oral preparations for fluid and electrolyte imbalance (0,0)
|
|
09.02.01.01 |
Oral potassium
(2,0)
|
|
|
Potassium removal
(5,0)
|
|
09.02.01.02 |
Oral sodium and water
(2,0)
|
|
|
Oral rehydration therapy (ORT)
(1,0)
|
|
09.02.01.03 |
Oral bicarbonate
(2,0)
|
|
09.02.02 |
Parenteral preparations for fluid and electrolyte imbalance
(2,0)
|
|
09.02.02.01 |
Electrolytes and water
(2,0)
|
|
|
Intravenous sodium
(2,0)
|
|
|
Intravenous glucose
(1,0)
|
|
|
Intravenous potassium
(1,0)
|
|
|
Bicarbonate and lactate
(2,0)
|
|
|
Water
(3,0)
|
|
09.02.02.02 |
Plasma and plasma substitutes
(2,0)
|
|
|
Plasma substitutes
(6,0)
|
|
09.03 |
Intravenous nutrition (0,0)
|
|
|
Supplementary preparations (0,0)
|
|
09.04 |
Oral nutrition
(3,0)
|
|
09.04.01 |
Foods for special diets
(1,0)
|
|
09.04.02 |
Enteral nutrition (0,0)
|
|
09.05 |
Minerals (0,0)
|
|
09.05.01 |
Calcium and magnesium (0,0)
|
|
09.05.01.01 |
Calcium supplements
(4,0)
|
|
09.05.01.02 |
Hypercalcaemia and hypercalciuria
(7,0)
|
|
09.05.01.03 |
Magnesium
(4,0)
|
|
09.05.02 |
Phosphorus (0,0)
|
|
09.05.02.01 |
Phosphate supplements
(4,0)
|
|
09.05.02.02 |
Phosphate-binding agents
(6,0)
|
|
09.05.03 |
Fluoride
(3,0)
|
|
09.05.04 |
Zinc
(2,0)
|
|
09.05.05 |
Selenium
(1,0)
|
|
09.06 |
Vitamins (0,0)
|
|
09.06.01 |
Vitamin A
(2,0)
|
|
09.06.02 |
Vitamin B group
(5,0)
|
|
|
Oral vitamin B complex preparations
(1,0)
|
|
|
Other compounds (0,0)
|
|
09.06.03 |
Vitamin C
(1,0)
|
|
09.06.04 |
Vitamin D
(7,0)
|
|
09.06.05 |
Vitamin E
(3,0)
|
|
09.06.06 |
Vitamin K
(2,0)
|
|
09.06.07 |
Multivitamin preparations
(3,0)
|
|
|
Vitamin and mineral supplements and adjuncts to synthetic diets
(5,0)
|
|
09.07 |
Bitters and tonics (0,0)
|
|
09.08 |
Metabolic disorders
(1,0)
|
|
09.08.01 |
Drugs used in metabolic disorders
(8,0)
|
|
|
Wilsons disease
(4,0)
|
|
|
Carnitine deficiency
(1,0)
|
|
|
Fabry's disease
(4,0)
|
|
|
Gaucher's disease
(2,0)
|
|
|
Mucopolysaccharidosis I
(4,0)
|
|
|
Pompe disease
(3,0)
|
|
|
Nephropathic cystinosis
(1,0)
|
|
|
Urea cycle disorders
(4,0)
|
|
09.08.02 |
Acute porphyrias
(2,0)
|
|
|
Drugs unsafe for use in acute porphyrias (0,0)
|
|
|
|
